Biomarin Pharmaceutical (bmrn 1.25 05/15/27)
13F holders, Q4 2024 (December 31)At the end of Q4 2024, 20 institutions reported holding Biomarin Pharmaceutical (bmrn 1.25 05/15/27) in their 13F filings, unchanged from Q3 2024. 4 opened new positions and 4 sold out. The largest holders were Loomis Sayles & Co. L P ($95.6M), Thrivent Financial for Lutherans ($13.7M) and Sonora Investment Management Group, LLC ($3.9M). One famous investor held it Ken Fisher (0.0% of Fisher Asset Management's portfolio).
- Company
- Biomarin Pharmaceutical (bmrn 1.25 05/15/27)
- CUSIP
- 09061GAK7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $2.7M |
| Exits | 4 | $396K |
All 13F filers, Q3 2024 → Q4 2024: 2,936,000 shares bought and 6,309,977 shares sold, net −3,373,977 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Loomis Sayles & Co. L P | 0.12% | Reduce -34.5% | 1,454,656 | $95.6M |
| Thrivent Financial for Lutherans | 0.03% | No change | 14,805,000 | $13.7M |
| Sonora Investment Management Group, LLC | 0.30% | Reduce -54.6% | 4,200,000 | $3.9M |
| Jane Street Group, LLC | 0.00% | New | 2,910,000 | $2.7M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 2,900,000 | $2.7M |
| Sei Investments Co. | 0.00% | No change | 524,000 | $486K |
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $279K |
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -8.7% | 178,000 | $165K |
| Cetera Investment Advisers | 0.00% | Reduce -15.2% | 168,000 | $156K |
| Stephens Inc. | 0.00% | Reduce -48.5% | 51,000 | $47K |
| Mariner, LLC | 0.00% | No change | 42,000 | $39K |
| Choreo, LLC | 0.00% | No change | 25,000 | $23K |
| Fisher Asset Management | 0.00% | New | 19,000 | $18K |
| Comerica Bank | 0.00% | No change | 15,000 | $14K |
| Capital Investment Advisors, LLC | 0.00% | No change | 11,000 | $10K |
| DAVENPORT & Co LLC | 0.00% | No change | 10,000 | $9K |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 5,000 | $5K |
| MAI Capital Management | 0.00% | New | 2,000 | $2K |
| Oddo BHF Asset Management Sas | 0.00% | Reduce -26.1% | 425 | $396 |
| Intellectus Partners, LLC | 0.00% | Reduce -2.1% | 324 | $301 |
"% of holder's portfolio" is BIOMARIN PHARMACEUTICAL (BMRN 1.25 05/15/27)'s weight in each manager's 13F, not the share of Biomarin Pharmaceutical (bmrn 1.25 05/15/27) the manager owns.